National
Family doctors today debate cannabinoids in chronic pain
Family doctors will today discuss the advantages of using cannabinoids in the treatment of chronic pain and raise awareness among health professionals about this therapy. The online event starts at 19 pm and is promoted by the Portuguese Association of General and Family Medicine (APMGF), aimed at family doctors, Agência Lusa said. Chronic pain affects one in three adults in Portugal.
The webinar, sponsored by Tilray Medical, is themed “Cannabinoids in Chronic Pain — Myths, Facts and Treatment Options”. The debate starts with the doctor Hugo Cordeiro, who will be the moderator, and includes the participation of Artur Aguiar, Radionologist at the IPO in Porto, and Raul Marques Pereira, coordinator of the Pain Study Group at APMGF.
Speaking to Lusa, Hugo Cordeiro, a doctor at Santa Casa da Misericórdia do Porto and a member of the APMGF Pain Study Group, said that “cannabinoids for medicinal purposes are a novelty in Portugal and, therefore, it is expected that this will be the first of several events aimed at disseminating the indications, risks and benefits” of these cannabis derivatives.
At the moment, he explained, “the greatest applicability of this type of product is in cases of patients who do not tolerate the necessary doses of other types of medication or those who are not controlled, despite the use of the maximum doses of this type of medication”.
“Some studies show that cannabinoids even make it possible to reduce the doses of other types of substances, which also have important side effects, and at the same time improve the quality of life” of users, stressed Cordeiro.
Asked if there are still barriers to taking this substance, the doctor said that, at this stage, “the biggest barriers” will be on the part of health professionals due to “ignorance” or “little disclosure”. “What we see on the ground is that patients and family members are already starting to be curious, who are often the first to ask health professionals about the possibility of using this type of substance”, said Hugo Cordeiro.
For the coordinator of the APMGF Pain Study Group, Raul Marques Pereira, “the biggest” limitation to the use of this substance will be the price, despite having some reimbursement. Regarding the advantages of its use, Raul Marques Pereira stated that “the drug has already been proven abroad”, so there is “a lot of safety” in its use.
In his view, “it would be important to be able to use it more”, which involves clarifying the doubts that may exist and the best clinical situations to use it in refractory pain.
In Portugal, one in three adults has chronic pain. “Of course not everyone will need cannabinoids, but there is a percentage that will need it”, said Raul Marques Pereira. As it is a “very wide” group of patients who can benefit from this type of therapy, “it is very important” to expose and discuss this therapy together, he stressed.
For doctor Hugo Cordeiro, the most important thing will be to demystify the dangers associated with these substances: “Be aware that these are products that have been the subject of an extensive safety and quality study and will continue to be so after their introduction on the market and even are associated with fewer side effects than some of the substances that are already in use today. “The use of cannabinoids can help with opioid savings and presents a favorable risk-benefit ratio when taken as prescribed and according to the correct indications”, he concludes.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
Thailand has found a solution where European countries still see a problem.
Reading Time: 13 minutes On my second trip to Thailand, I was once again pleasantly surprised. After visiting several...
The Royal Thai Embassy in Tokyo promotes "Adapting International Hemp to Japan's New Regulations"
Reading Time: 3 minutes The International Business Meeting “Adapting the International Market...” will take place tomorrow, November 13, 2025.
Portugal: Infarmed updates lists and removes licenses from two more medicinal cannabis companies.
Reading Time: 2 minutes. Infarmed has updated the public list of entities licensed for activities with medicinal cannabis in Portugal. The...
Portocanna strengthens its Hexacan portfolio with a new sublingual solution containing 20% THC.
Reading Time: 2 minutes. The Portuguese company Portocanna announced the launch of Hexacan® Hexa 01 Cannabis Oil Extract THC 20%,...
Cypress Hill confirmed for Rock in Rio Lisboa 2026
Reading Time: 2 minutes. The legendary American band Cypress Hill, whose hits "Insane in the Brain" and "Hits from the Bong"...
USA: Green Thumb Industries workers secure collective agreement after 45-day strike.
Reading Time: < 1 minute Workers at Green Thumb Industries, one of the largest multi-state cannabis companies in the United States...
Switzerland: Pacrim takes control of Medropharm and prepares for a new phase of expansion in medicinal cannabis.
Reading Time: 2 minutes. Pacrim has acquired two-thirds of the Swiss company Medropharm, thus gaining control of the company and its operations.
South Africa: Researchers discover rare phenolic compounds in cannabis leaves.
Reading Time: 4 minutes. Researchers at Stellenbosch University in South Africa have discovered that flavoalkaloids are produced in the leaves of the plant...
Covilhã – Dismantling of two cannabis greenhouses
Reading Time: < 1 minute The Castelo Branco Territorial Command, through the Criminal Investigation Unit (NIC) of Covilhã, in...
Tokyo will host the Japan International Hemp Expo on November 14th and 15th, 2025.
Reading Time: 4 minutes. For the first time since the legal reform, Japan opens its doors to the global hemp industry...
